TSND Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
TerrAscend Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.09 |
| 52 Week High | CA$3.21 |
| 52 Week Low | CA$0.93 |
| Beta | 1.89 |
| 11 Month Change | -34.34% |
| 3 Month Change | -45.36% |
| 1 Year Change | -50.23% |
| 33 Year Change | -86.66% |
| 5 Year Change | -67.94% |
| Change since IPO | -9.92% |
Recent News & Updates
Recent updates
Is TerrAscend (TSE:TSND) A Risky Investment?
Sep 03
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Apr 25What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
Mar 10Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
Jan 24Is TerrAscend (TSE:TSND) A Risky Investment?
Dec 25TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
Aug 13TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
Jul 03TerrAscend (CSE:TER) Is Making Moderate Use Of Debt
Mar 06Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?
Dec 21Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates
Aug 14Is TerrAscend (CSE:TER) Using Too Much Debt?
Jul 15Shareholder Returns
| TSND | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -10.7% | -6.1% | 0.7% |
| 1Y | -50.2% | -22.3% | 21.7% |
Return vs Industry: TSND underperformed the Canadian Pharmaceuticals industry which returned -22.8% over the past year.
Return vs Market: TSND underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| TSND volatility | |
|---|---|
| TSND Average Weekly Movement | 14.9% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TSND's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: TSND's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
| TSND fundamental statistics | |
|---|---|
| Market cap | CA$409.15m |
| Earnings (TTM) | -CA$129.35m |
| Revenue (TTM) | CA$445.84m |
0.7x
P/S Ratio-2.5x
P/E RatioIs TSND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSND income statement (TTM) | |
|---|---|
| Revenue | US$318.89m |
| Cost of Revenue | US$164.49m |
| Gross Profit | US$154.40m |
| Other Expenses | US$246.92m |
| Earnings | -US$92.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 48.42% |
| Net Profit Margin | -29.01% |
| Debt/Equity Ratio | 96.0% |
How did TSND perform over the long term?
See historical performance and comparison